Hemodynamics and respiratory and metabolic variables collected during the equilibrium phase. * Wilcoxonâs test for paired samples. (DOCX 18Â kb
Baseline characteristics by quartiles of baseline serum bicarbonate. Table S2. Transition matrix sho...
Table S2. AUCs for AKI stratified according to admission serum glucose in diabetic patients. (DOC 35...
Table S2. AUC-ROC of biomarkers for established AKI, later-onset AKI and progressive AKI. AUC-ROC va...
Respiratory variables categorized throughout the study based on the group. Data are shown as the med...
Estimating the Difference between Bicarbonate Dialysate Inflow and Arterial Blood Bicarbonate (mEq/L...
Selected renal adverse events and serious adverse events (safety population). (DOCX 11Â kb
Patient Peridialytic Bicarbonate Concentrations in the Blood and Dialysate by Acid Concentrate Type....
Classification of participants renal function according to RIFLE criteria at the entry study. Table ...
Table S1. VIF and tolerance values of the variables in Model 3 (for composite outcomes). (DOCX 17 kb
Table S1. Longitudinal laboratory measurements and ESA doses for baseline ESA users and ESA Naives. ...
Table S2. VIF and tolerance values of the variables in Model 3 (for ESRD alone). (DOCX 16 kb
Evolution of blood and urine biological parameters in the three groups. Results are expressed as med...
Table S1. Correlations among three biomarkers at ICU admission. The correlation of biomarkers with o...
Probability of AKI during the stay in the surgical ICU. AKI probability according to maximum serum c...
Table S1. Baseline characteristics in individuals with and without reviewer confirmed arrhythmia dur...
Baseline characteristics by quartiles of baseline serum bicarbonate. Table S2. Transition matrix sho...
Table S2. AUCs for AKI stratified according to admission serum glucose in diabetic patients. (DOC 35...
Table S2. AUC-ROC of biomarkers for established AKI, later-onset AKI and progressive AKI. AUC-ROC va...
Respiratory variables categorized throughout the study based on the group. Data are shown as the med...
Estimating the Difference between Bicarbonate Dialysate Inflow and Arterial Blood Bicarbonate (mEq/L...
Selected renal adverse events and serious adverse events (safety population). (DOCX 11Â kb
Patient Peridialytic Bicarbonate Concentrations in the Blood and Dialysate by Acid Concentrate Type....
Classification of participants renal function according to RIFLE criteria at the entry study. Table ...
Table S1. VIF and tolerance values of the variables in Model 3 (for composite outcomes). (DOCX 17 kb
Table S1. Longitudinal laboratory measurements and ESA doses for baseline ESA users and ESA Naives. ...
Table S2. VIF and tolerance values of the variables in Model 3 (for ESRD alone). (DOCX 16 kb
Evolution of blood and urine biological parameters in the three groups. Results are expressed as med...
Table S1. Correlations among three biomarkers at ICU admission. The correlation of biomarkers with o...
Probability of AKI during the stay in the surgical ICU. AKI probability according to maximum serum c...
Table S1. Baseline characteristics in individuals with and without reviewer confirmed arrhythmia dur...
Baseline characteristics by quartiles of baseline serum bicarbonate. Table S2. Transition matrix sho...
Table S2. AUCs for AKI stratified according to admission serum glucose in diabetic patients. (DOC 35...
Table S2. AUC-ROC of biomarkers for established AKI, later-onset AKI and progressive AKI. AUC-ROC va...